SCHEMBL3661954

SCHEMBL3661954

O=C(c1ccccc1)c1cc([N+](=O)[O-])ccc1Cl

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.64
KDM4E B2RXH2 1/20 0.64
RORC P51449 6/20 0.63
LMNA P02545 5/20 0.63
MEN1 O00255 4/20 0.63
KMT2A Q03164 4/20 0.63
MAPT P10636 3/20 0.63
SMN1; SMN2 Q16637 3/20 0.63
MAPK1 P28482 3/20 0.63
TP53 P04637 1/20 0.63
CYP1A2 P05177 1/20 0.63
CYP3A4 P08684 1/20 0.63
CYP2D6 P10635 1/20 0.63
CYP2C9 P11712 1/20 0.63
PKM P14618 1/20 0.63
TSHR P16473 1/20 0.63
NFKB1 P19838 1/20 0.63
CYP2C19 P33261 1/20 0.63
PPARG P37231 1/20 0.63
THPO P40225 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16922169 1.00 NPSR1 (0.64) NPSR1KDM4ERORCLMNAMEN1
Phosphine SCHEMBL28235319 0.98 NPSR1 (0.62) NPSR1KDM4ERORCLMNAMEN1
Acetic Acid SCHEMBL27779261 0.96 NPSR1 (0.63) NPSR1KDM4ERORCLMNAMEN1
Pyruvate SCHEMBL27565886 0.93 NPSR1 (0.60) NPSR1KDM4ERORCLMNAMEN1
Acetamide SCHEMBL28123803 0.93 NPSR1 (0.60) NPSR1KDM4ERORCLMNAMEN1
SCHEMBL10902402 0.90 NPSR1 (0.71) NPSR1KDM4ERORCLMNAMEN1
SCHEMBL10902888 0.89 TSHR (0.59) NPSR1KDM4ERORCLMNAMEN1
SCHEMBL2394121 0.88 KDM4E (0.67) NPSR1KDM4ERORCLMNAMEN1
SCHEMBL6314599 0.88 MAPK1 (0.68) NPSR1RORCLMNAMEN1KMT2A
SCHEMBL10953243 0.87 HSD17B10 (0.62) NPSR1KDM4ERORCLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 288 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10092786-B2 Fire extinguishing composition comprising aldoketones compound XI'AN WESTPEACE FIRE TECHNOLOGY CO., LTD. (CN) 2018-10-09 US claimed
CN-108373415-A A kind of preparation method of two (bis- chloro- 5- nitrobenzophenones of 2,4-) carbonic esters 常州大学 2018-08-07 CN claimed
CN-106496056-B A kind of synthetic method of arylamides 中国人民解放军63975部队 2018-03-02 CN claimed
CN-107200708-A A kind of preparation method of vismodegib 新发药业有限公司 2017-09-26 CN claimed
CN-105646231-B A kind of preparation method of the nitrophenol of 2,4 dichloro 5 连云港市金囤农化有限公司 2017-09-22 CN claimed
CN-105175284-B Amides compound, preparation method and its medical usage 中国药科大学 2017-06-16 CN claimed
CN-106699570-A Synthesis method for (2-chloro-5-iodophenyl)(4-fluorophenyl)ketone 山东铂源药业有限公司 2017-05-24 CN claimed
CN-106366000-A Preparation method of 2-chloro-5-nitrobenzophenone 枣阳凤泽精细化工有限公司 2017-02-01 CN claimed
CN-205700577-U Produce the reactor of 2-chloro-5-nitro benzophenone 枣阳凤泽精细化工有限公司 2016-11-23 CN claimed
US-20160332016-A1 Fire Extinguishing Composition Comprising Aldoketones Compound NANO FIRE, LLC 2016-11-17 US claimed
CN-102057918-A Application of 4-alkyl-5-(1,2,4-triazole-1-yl)-2-benzyl imino thiazole in preparation of weedicide UNIV HUNAN 2011-05-18 CN claimed
CN-101152185-B Use of heterocyclic compounds as SCCE inhibitors AREXIS AB 2010-12-08 CN claimed
CN-101184487-B Bicyclic pyrazole compounds as antibacterial agents JANSSEN PHARMACEUTICA NV 2010-11-03 CN claimed
CN-100518740-C Pharmaceutical use of heterocyclic compounds as SCCE inhibitors AREXIS AB (SE) 2009-07-29 CN claimed
EP-1794175-B1 PROCESS FOR THE PREPARATION OF ESTRONE AND/OR ESTRADIOL-DERIVATES ORGANON NV (NL) 2008-08-13 EP claimed
CN-101184487-A Bicyclic pyrazole compounds as antibacterial agents JANSSEN PHARMACEUTICA NV (BE) 2008-05-21 CN claimed
US-20070299268-A1 Process for the Preparation of Estrone and/or Estradiol-Derivates N.V. ORGANON (NL) 2007-12-27 US claimed
CN-101010332-A Process for the preparation of estrone and/or estradiol derivatives ORGANON NV (NL) 2007-08-01 CN claimed
EP-1794175-A1 PROCESS FOR THE PREPARATION OF ESTRONE AND/OR ESTRADIOL-DERIVATES N.V. Organon (NL) 2007-06-13 EP claimed
WO-2006021554-A1 PROCESS FOR THE PREPARATION OF ESTRONE AND/OR ESTRADIOL-DERIVATES N.V. ORGANON (NL) 2006-03-02 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299268-A1 Process for the Preparation of Estrone and/or Estradiol-Derivates CYP19A1, HSD17B11, HSD17B7 NPSR1 530/4885KDM4E 388/4885RORC 1783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.